Krishan Jethwa (@krishanjethwa) 's Twitter Profile
Krishan Jethwa

@krishanjethwa

GI Radiation Oncologist | Associate PD @MayoRadOnc @MayoClinic | Passions for #PatientCare, #MedEd, QoL, #PublicHealth, and #ClinicalTrials | Views are my own

ID: 787697800985268225

calendar_today16-10-2016 16:52:45

1,1K Tweet

3,3K Followers

1,1K Following

The Accelerators Podcast ☢️ (@acceleratorsro) 's Twitter Profile Photo

On the latest TAP, we host GI all-stars @krishanjethwa and @niusanford to discuss one of the hottest topics from #ASCO24. ESOPEC moved the needle for patients with GEJ adeno 🙌... Is ☢️ done in this setting? Update your knowledge of esophagus cancer in less than 1 hour! #MedEd

On the latest TAP, we host GI all-stars @krishanjethwa and @niusanford to discuss one of the hottest topics from #ASCO24.

ESOPEC moved the needle for patients with GEJ adeno 🙌...

Is ☢️ done in this setting?

Update your knowledge of esophagus cancer in less than 1 hour! #MedEd
Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

What imaging do you use to follow anal cancer patients s/p chemoRT? We do: PET at 10-12 weeks & if still uptake, another ~3 mo later. Once normalized, CT CAP q6-12 mo. But this isn't consistent w NCCN guidelines – which recommends no f/u PET, no short-term imaging at all.

What imaging do you use to follow anal cancer patients s/p chemoRT?

We do: PET at 10-12 weeks & if still uptake, another ~3 mo later. Once normalized, CT CAP q6-12 mo.

But this isn't consistent w NCCN guidelines – which recommends no f/u PET, no short-term imaging at all.
Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

Educational session for trainees and practicing oncologists on esophagus/GEJ cancers, the esopec study, how it fits in contemporary practice, and future directions. Thanks for hosting Dr. Nina Niu Sanford and I! Check it out!!

Gerard Walls (@gwalls89) 's Twitter Profile Photo

Thoracic #RadOncs - check out our new paper in JACC CardioOnc! Simple heart features on planning CT were associated with risk of specific cardiac events after RT for NSCLC (n=478) Is it time we got Cardiology input on some of our patients? Thread (/14)...

Thoracic #RadOncs - check out our new paper in JACC CardioOnc!
 
Simple heart features on planning CT were associated with risk of specific cardiac events after RT for NSCLC (n=478)
 
Is it time we got Cardiology input on some of our patients?
 
 Thread (/14)...
Gerry Hanna (@gerryhanna) 's Twitter Profile Photo

Enticing results reported in the TORCH study at #ASCO24 and just published in Journal of Clinical Oncology 📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B Full paper 🔗: ascopubs.org/doi/abs/10.120…

Enticing results reported in the TORCH study at #ASCO24 and just published in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> 

📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B  

Full paper 🔗: ascopubs.org/doi/abs/10.120…
Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🚨PRODIGE23🚨 Long term results now published! T3-4 rectal adenocarcinoma Randomized: CRT➡️🔪➡️FOLFOX mFOLFIRINOX ➡️ CRT➡️🔪➡️FOLFOX ✅✅✅Improved OS!!! Looking forward to JANUS clarifying if TNT with FOLFIRINOX vs. FOLFOX improves cCR and/or DFS/OS pubmed.ncbi.nlm.nih.gov/38986769/

🚨PRODIGE23🚨

Long term results now published!
T3-4 rectal adenocarcinoma
Randomized:
CRT➡️🔪➡️FOLFOX
mFOLFIRINOX ➡️ CRT➡️🔪➡️FOLFOX

✅✅✅Improved OS!!!

Looking forward to JANUS clarifying if TNT with FOLFIRINOX vs. FOLFOX improves cCR and/or DFS/OS

pubmed.ncbi.nlm.nih.gov/38986769/
OncoAlert (@oncoalert) 's Twitter Profile Photo

The OncoAlert 🚨Round UP NOW OUT Covering July 5-11, 2024 REGISTER at Oncoalert360.com or oncoalert.m-pages.com/nhMpwe/oncoale… Discussing: GU Cancers ✅Renal function after SABR in 1ry #KidneyCancer sciencedirect.com/science/articl… ✅PDL1& Nectin4 expression in #BladderCancer out on

Mayo Clinic (@mayoclinic) 's Twitter Profile Photo

Mayo Clinic is once again top-ranked in more specialties than any other hospital and is the only healthcare organization with two hospitals on the U.S. News Honor Roll in the U.S. News & World Report "Best Hospitals" rankings for 2024-2025. Read more: mayocl.in/4f5b3mf

Erman Akkus (@erman_akkus) 's Twitter Profile Photo

☢️Celiac plexus radiation for pain management in pancreatic cancer The Lancet Oncology ✅At 3 weeks, 53% of the patients had at least a partial pain response ✅A non-invasive, relatively safe treatment 👉doi.org/10.1016/S1470-… The Lancet ESTRO ASTRO PanCAN M. Bolton

☢️Celiac plexus radiation for pain management in pancreatic cancer
<a href="/TheLancetOncol/">The Lancet Oncology</a> 

✅At 3 weeks, 53% of the patients had at least a partial pain response

✅A non-invasive, relatively safe treatment 

👉doi.org/10.1016/S1470-…

<a href="/TheLancet/">The Lancet</a> <a href="/ESTRO_RT/">ESTRO</a> <a href="/ASTRO_org/">ASTRO</a> <a href="/PanCAN/">PanCAN</a> <a href="/5_utr/">M. Bolton</a>
Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Great to see this out- congrats Yaacov Lawrence Md, Laura Dawson et al. Retroperitoneal pain due to tumor celiac plexus involvement can be debilitating & narcotic refractory 25 Gy x 1 improving pain in 53% is remarkable! RCT of RT v celiac block hopefully forthcoming NRG Oncology🤞1/3

Erman Akkus (@erman_akkus) 's Twitter Profile Photo

📍Treatment of localized rectal cancer ✅Simplified algorithm of ESMO - Eur. Oncology guideline ✅Variation in inclusion criteria among studies ✅Different TNT strategies 👇 #ESMOGI24 Deniz Can Guven Dr Joseph McCollom DO Krishan Jethwa OncoAlert #Cancer #Oncology #MedX

📍Treatment of localized rectal cancer

✅Simplified algorithm of <a href="/myESMO/">ESMO - Eur. Oncology</a> guideline
✅Variation in inclusion criteria among studies
✅Different TNT strategies
👇

#ESMOGI24 <a href="/DenizCanGuven1/">Deniz Can Guven</a> <a href="/realbowtiedoc/">Dr Joseph McCollom DO</a> <a href="/KrishanJethwa/">Krishan Jethwa</a> <a href="/OncoAlert/">OncoAlert</a> #Cancer #Oncology #MedX
Mark Lewis, MD, FASCO (@marklewismd) 's Twitter Profile Photo

Another week, another tumor board where I referenced this brilliant Krishan Jethwa flowchart to guide multidisciplinary discussion of rectal cancer management #crcsm

Another week, another tumor board where I referenced this brilliant <a href="/KrishanJethwa/">Krishan Jethwa</a> flowchart to guide multidisciplinary discussion of rectal cancer management #crcsm
Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🚨 Aspiring Rad Oncs- Check this out! Please join us to learn more about our program Mayo Clinic Radiation Oncology and how we can support you pursuing your professional/personal/career goals!

Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

Alright friends- I like the "inclusive" algorithm as it acknowledges suitable options with flexibility to balance nuance and most importantly, patient preferences. But... I was asked what I prefer. By request- here is my more limited decision pathway- open to feedback 🙂🤓

Alright friends- I like the  "inclusive" algorithm as it acknowledges suitable options with flexibility to balance nuance and most importantly, patient preferences.

But... I was asked what I prefer. By request- here is my more limited decision pathway- open to feedback 🙂🤓
PDBrown (@pdbrownonc) 's Twitter Profile Photo

Any benefit Carbon (vs. Protons) for Sacral Chordoma? In this randomized phase II no signif differences btwn study arms sciencedirect.com/science/articl…

Any benefit Carbon (vs. Protons) for Sacral Chordoma?
In this randomized phase II no signif differences btwn study arms 
sciencedirect.com/science/articl…
Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🚨Interested in a quick read on patient-centric approaches to local treatment decisions for patients with rectal cancer and opportunities for the future❓❓❓ Check this out! pubmed.ncbi.nlm.nih.gov/39127067/ Mayo Clinic Radiation Oncology COLONTOWN #CRC

Jelena Lukovic, MD FRCPC MPH (@j_lukovic) 's Twitter Profile Photo

Single fraction RT (8Gy) significantly improves hepatic pain compared with best supportive care and can be considered standard palliative treatment. No increase in toxicity. Laura Dawson CCTG thelancet.com/journals/lanon…